Targeting AURKA in Cancer: molecular mechanisms and opportunities for Cancer therapy

R Du, C Huang, K Liu, X Li, Z Dong - Molecular cancer, 2021 - Springer
Aurora kinase A (AURKA) belongs to the family of serine/threonine kinases, whose
activation is necessary for cell division processes via regulation of mitosis. AURKA shows …

Computational methods in drug discovery

G Sliwoski, S Kothiwale, J Meiler, EW Lowe - Pharmacological reviews, 2014 - ASPET
Computer-aided drug discovery/design methods have played a major role in the
development of therapeutically important small molecules for over three decades. These …

Irreversible protein kinase inhibitors: balancing the benefits and risks

T Barf, A Kaptein - Journal of medicinal chemistry, 2012 - ACS Publications
In the relatively young but expanding field of irreversible kinase inhibitor drug discovery,
there are two main developments that are of central importance. First, the patients have …

Pyrimidine-based EGFR TK inhibitors in targeted cancer therapy

A Ayati, S Moghimi, M Toolabi, A Foroumadi - European Journal of …, 2021 - Elsevier
Despite significant improvements of new treatment options, cancer continues to represent as
one of the most common and fatal disease. The EGFR signaling pathway is considered as a …

Overview of recent strategic advances in medicinal chemistry

G Wu, T Zhao, D Kang, J Zhang, Y Song… - Journal of medicinal …, 2019 - ACS Publications
Introducing novel strategies, concepts, and technologies that speed up drug discovery and
the drug development cycle is of great importance both in the highly competitive …

A comprehensive review on Aurora kinase: Small molecule inhibitors and clinical trial studies

AC Borisa, HG Bhatt - European journal of medicinal chemistry, 2017 - Elsevier
Aurora kinase belongs to serine/threonine kinase family which controls cell division.
Therapeutic inhibition of Aurora kinase showed great promise as probable anticancer …

Pyrimidine and fused pyrimidine derivatives as promising protein kinase inhibitors for cancer treatment

KRA Abdellatif, RB Bakr - Medicinal Chemistry Research, 2021 - Springer
Pyrimidine ring and its fused derivatives including pyrazolo [3, 4-d] pyrimidine, pyrido [2, 3-d]
pyrimidine, quinazoline, and furo [2, 3-d] pyrimidine compounds had received much interest …

Structure-based virtual screening approach for discovery of covalently bound ligands

D Toledo Warshaviak, G Golan… - Journal of chemical …, 2014 - ACS Publications
We present a fast and effective covalent docking approach suitable for large-scale virtual
screening (VS). We applied this method to four targets (HCV NS3 protease, Cathepsin K …

Protein kinase inhibitor design by targeting the Asp-Phe-Gly (DFG) motif: the role of the DFG motif in the design of epidermal growth factor receptor inhibitors

YH Peng, HY Shiao, CH Tu, PM Liu… - Journal of medicinal …, 2013 - ACS Publications
The Asp-Phe-Gly (DFG) motif plays an important role in the regulation of kinase activity.
Structure-based drug design was performed to design compounds able to interact with the …

Design, synthesis, and biological evaluation of novel conformationally constrained inhibitors targeting epidermal growth factor receptor threonine790→ …

S Chang, L Zhang, S Xu, J Luo, X Lu… - Journal of Medicinal …, 2012 - ACS Publications
The EGFRT790M mutant contributes approximately 50% to clinically acquired resistance
against gefitinib or erlotinib. However, almost all the single agent clinical trials of the second …